Multimorbidity in osteoarthritis
This review is focused on the issue of terminology in patients with multiple coexisting diseases in modern clinical practice. We articulate that multimorbidity is one of the leading problems in the field of public healthcare and that the treatment of these patients demands an integral approach deriv...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2022-07-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3178 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849400946827722752 |
|---|---|
| author | E. A. Taskina L. I. Alekseeva N. G. Kashevarova A. M. Lila E. L. Nasonov |
| author_facet | E. A. Taskina L. I. Alekseeva N. G. Kashevarova A. M. Lila E. L. Nasonov |
| author_sort | E. A. Taskina |
| collection | DOAJ |
| description | This review is focused on the issue of terminology in patients with multiple coexisting diseases in modern clinical practice. We articulate that multimorbidity is one of the leading problems in the field of public healthcare and that the treatment of these patients demands an integral approach derived from the combined nature of the pathology . It was shown that multiple coexisting diseases have a negative effect both on the course of osteoarthritis (OA) and its concomitant ailments, including higher risk of polypharmacy and death. Extra attention is paid to slow-acting symptomatic drugs, which often have positive pleiotropic effects towards both the OA and the concomitant diseases. In particular, there is more and more research showing evidence of the beneficial effects of chondroitin sulfate both on the OA treatment effectiveness as well as on the terms of cardiometabolic prognosis, mitigation of glucose metabolism deficiency and mortality. |
| format | Article |
| id | doaj-art-2a7e4501ae4e43b7a573c9d31335fdce |
| institution | Kabale University |
| issn | 1995-4484 1995-4492 |
| language | Russian |
| publishDate | 2022-07-01 |
| publisher | IMA PRESS LLC |
| record_format | Article |
| series | Научно-практическая ревматология |
| spelling | doaj-art-2a7e4501ae4e43b7a573c9d31335fdce2025-08-20T03:37:53ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922022-07-0160330631310.47360/1995-4484-2022-306-3132810Multimorbidity in osteoarthritisE. A. Taskina0L. I. Alekseeva1N. G. Kashevarova2A. M. Lila3E. L. Nasonov4V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian FederationV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian FederationV.A. Nasonova Research Institute of Rheumatology; I.M. Sechenov First Moscow State Medical University of the Ministry of Health Care of Russian Federation (Sechenov University)This review is focused on the issue of terminology in patients with multiple coexisting diseases in modern clinical practice. We articulate that multimorbidity is one of the leading problems in the field of public healthcare and that the treatment of these patients demands an integral approach derived from the combined nature of the pathology . It was shown that multiple coexisting diseases have a negative effect both on the course of osteoarthritis (OA) and its concomitant ailments, including higher risk of polypharmacy and death. Extra attention is paid to slow-acting symptomatic drugs, which often have positive pleiotropic effects towards both the OA and the concomitant diseases. In particular, there is more and more research showing evidence of the beneficial effects of chondroitin sulfate both on the OA treatment effectiveness as well as on the terms of cardiometabolic prognosis, mitigation of glucose metabolism deficiency and mortality.https://rsp.mediar-press.net/rsp/article/view/3178multimorbidityosteoarthritispleiotropic effectssysadoaalflutop |
| spellingShingle | E. A. Taskina L. I. Alekseeva N. G. Kashevarova A. M. Lila E. L. Nasonov Multimorbidity in osteoarthritis Научно-практическая ревматология multimorbidity osteoarthritis pleiotropic effects sysadoa alflutop |
| title | Multimorbidity in osteoarthritis |
| title_full | Multimorbidity in osteoarthritis |
| title_fullStr | Multimorbidity in osteoarthritis |
| title_full_unstemmed | Multimorbidity in osteoarthritis |
| title_short | Multimorbidity in osteoarthritis |
| title_sort | multimorbidity in osteoarthritis |
| topic | multimorbidity osteoarthritis pleiotropic effects sysadoa alflutop |
| url | https://rsp.mediar-press.net/rsp/article/view/3178 |
| work_keys_str_mv | AT eataskina multimorbidityinosteoarthritis AT lialekseeva multimorbidityinosteoarthritis AT ngkashevarova multimorbidityinosteoarthritis AT amlila multimorbidityinosteoarthritis AT elnasonov multimorbidityinosteoarthritis |